PMC Links for GEO Profiles (Select 48691979) - PMC

Links from GEO Profiles

Items: 1 to 20 of 1480

<< First< Prev

Page of 74

Select item 112721841.

BRCA1 and 53BP1 Regulate Reprogramming Efficiency by Mediating DNA Repair Pathway Choice at Replication-associated Double-Strand Breaks

Daniela Georgieva, Ning Wang, Angelo Taglialatela, Stepan Jerabek, Colleen R. Reczek, Pei Xin Lim, Julie Sung, Qian Du, Michiko Horiguchi, Maria Jasin, Alberto Ciccia, Richard Baer, Dieter Egli

Cell Rep. Author manuscript; available in PMC 2024 Jul 25.

Published in final edited form as: Cell Rep. 2024 Apr 23; 43(4): 114006. Published online 2024 Mar 30. doi: 10.1016/j.celrep.2024.114006

PMCID:: PMC11272184

Abstract Article PDF–2.7M

Select item 111598402.

Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non‐small‐cell lung cancer

Min Kim, Hyo‐Gyoung Kang, Shin Yup Lee, Hyung Cheol Lee, Eung Bae Lee, Yi Young Choi, Won Kee Lee, Sukki Cho, Guang Jin, Hyo‐Sung Jheon, Ji Woong Son, Myung‐Hoon Lee, Deuk Kju Jung, Seung Ick Cha, Chang Ho Kim, Young Mo Kang, Sin Kam, Tae Hoon Jung, Sanghoon Jheon, Jae Yong Park

Cancer Sci. 2010 Nov; 101(11): 2436–2442. Published online 2010 Jul 31. doi: 10.1111/j.1349-7006.2010.01699.x

PMCID:: PMC11159840

Abstract Article PDF–209K

Select item 111598113.

BRCA1 contributes to transcription‐coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein

Leizhen Wei, Li Lan, Akira Yasui, Kiyoji Tanaka, Masafumi Saijo, Ayako Matsuzawa, Risa Kashiwagi, Emiko Maseki, Yiheng Hu, Jeffrey D. Parvin, Chikashi Ishioka, Natsuko Chiba

Cancer Sci. 2011 Oct; 102(10): 1840–1847. Published online 2011 Aug 18. doi: 10.1111/j.1349-7006.2011.02037.x

PMCID:: PMC11159811

Abstract Article PDF–473K

Select item 111589074.

Cross‐sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

Kokichi Sugano, Seigo Nakamura, Jiro Ando, Shin Takayama, Hiroyuki Kamata, Isao Sekiguchi, Megumi Ubukata, Tetsuro Kodama, Masami Arai, Fujio Kasumi, Yasuo Hirai, Tadashi Ikeda, Hiromitsu Jinno, Masaki Kitajima, Daisuke Aoki, Akira Hirasawa, Yuko Takeda, Kumiko Yazaki, Takashi Fukutomi, Takayuki Kinoshita, Ryuichiro Tsunematsu, Teruhiko Yoshida, Masako Izumi, Shino Umezawa, Hiroshi Yagata, Hiroko Komatsu, Naoko Arimori, Noriko Matoba, Nobuhisa Gondo, Shiro Yokoyama, Yoshio Miki

Cancer Sci. 2008 Oct; 99(10): 1967–1976. Published online 2008 Oct 9. doi: 10.1111/j.1349-7006.2008.00944.x

PMCID:: PMC11158907

Abstract Article PDF–293K

Select item 111588405.

BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin

Hyun Jeong Shim, Joo Young Yun, Jun Eul Hwang, Woo Kyun Bae, Sang Hee Cho, Ji Hee Lee, Hee Nam Kim, Min Ho Shin, Sun Seog Kweon, Jae Hyuk Lee, Hyeoung Joon Kim, Ik Joo Chung

Cancer Sci. 2010 May; 101(5): 1247–1254. Published online 2010 Mar 12. doi: 10.1111/j.1349-7006.2010.01514.x

PMCID:: PMC11158840

Abstract Article PDF–215K

Select item 111587106.

Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer‐related cells

Mohamed K. El‐Tanani, Hiu‐Fung Yuen, Zhanzhong Shi, Angela Platt‐Higgins, Niamh E. Buckley, Paul B. Mullan, Denis Paul Harkin, Patrick G. Johnston, Philip S. Rudland

Cancer Sci. 2010 Jun; 101(6): 1354–1360. Published online 2010 Mar 10. doi: 10.1111/j.1349-7006.2010.01561.x

PMCID:: PMC11158710

Abstract Article PDF–474K

Select item 111585937.

Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3′‐kinase–Akt pathway

Yan‐Qiu Wang, Jia‐Rong Zhang, Shuang‐Di Li, Yin‐Yan He, Yi‐Xia Yang, Xue‐Lian Liu, Xiao‐Ping Wan

Cancer Sci. 2010 Jul; 101(7): 1618–1623. Published online 2010 Mar 17. doi: 10.1111/j.1349-7006.2010.01568.x

PMCID:: PMC11158593

Abstract Article PDF–568K

Select item 111584078.

BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer

Yanglin Chen, Jing Zhou, Ye Xu, Zhaosheng Li, Xianzi Wen, Lihua Yao, Yuntao Xie, Dajun Deng

Cancer Sci. 2009 Sep; 100(9): 1663–1667. Published online 2009 May 18. doi: 10.1111/j.1349-7006.2009.01225.x

PMCID:: PMC11158407

Abstract Article PDF–714K

Select item 110268449.

Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan

Hilal Ahmad, Asif Ali, Roshan Ali, Ali Talha Khalil, Ishaq Khan, Mah Muneer Khan, Mohammed Alorini

Neoplasia. 2024 May; 51: 100989. Published online 2024 Mar 27. doi: 10.1016/j.neo.2024.100989

PMCID:: PMC11026844

Abstract Article PDF–23M

Select item 1097026710.

Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women

Nisreen Al-Moghrabi, Maram Al-Showimi, Amal Alqahtani, Osama Almalik, Hamed Alhusaini, Ghdah Almalki, Ajawhara Saad, Elaf Alsunayi

Int J Mol Sci. 2024 Mar; 25(6): 3108. Published online 2024 Mar 7. doi: 10.3390/ijms25063108

PMCID:: PMC10970267

Abstract Article PDF–1.0M

Select item 1094102511.

Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers

Brant Gracia, Patricia Montes, Angelica Maria Gutierrez, Banu Arun, Georgios Ioannis Karras

Cell Rep. Author manuscript; available in PMC 2024 Mar 15.

Published in final edited form as: Cell Rep. 2024 Feb 27; 43(2): 113803. Published online 2024 Feb 17. doi: 10.1016/j.celrep.2024.113803

PMCID:: PMC10941025

Abstract Article PDF–2.1M

Select item 1090555212.

BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer

Caroline Stahnke Richau, Nicole de Miranda Scherer, Bruna Palma Matta, Elvismary Molina de Armas, Fábio Carvalho de Barros Moreira, Anke Bergmann, Claudia Bessa Pereira Chaves, Mariana Boroni, Anna Claudia Evangelista dos Santos, Miguel Angelo Martins Moreira

Cancer Med. 2024 Feb; 13(3): e6729. Published online 2024 Feb 2. doi: 10.1002/cam4.6729

PMCID:: PMC10905552

Abstract Article PDF–1.0M

Select item 1088368313.

Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health

Elisabetta De Matteis, Maria Rosaria Tumolo, Paolo Tarantino, Mariangela Ciccarese, Tiziana Grassi, Francesco Bagordo, Maria Rita De Giorgio, Emanuele Rizzo, Graziana Ronzino

Oncotarget. 2024; 15: 134–141. Published online 2024 Feb 22. doi: 10.18632/oncotarget.28561

PMCID:: PMC10883683

Abstract Article PDF–412K

Select item 1087054714.

Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis

Matan Ben-Zion Berliner, Shlomit Yust-Katz, Inbar Lavie, Yael Goldberg, Inbal Kedar, Rinat Yerushalmi

BMC Cancer. 2024; 24: 219. Published online 2024 Feb 16. doi: 10.1186/s12885-024-11975-7

PMCID:: PMC10870547

Abstract Article PDF–1.1M

Select item 1086937015.

Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family

James M. Chan, Mark Clendenning, Sharelle Joseland, Peter Georgeson, Khalid Mahmood, Jihoon E. Joo, Romy Walker, Julia Como, Susan Preston, Shuyi Marci Chai, Yen Lin Chu, Aaron L. Meyers, Bernard J. Pope, David Duggan, J. Lynn Fink, Finlay A. Macrae, Christophe Rosty, Ingrid M. Winship, Mark A. Jenkins, Daniel D. Buchanan

Fam Cancer. 2024; 23(1): 9–21. Published online 2023 Dec 8. doi: 10.1007/s10689-023-00351-2